Thomas Willoughby joined BioPharma Services in 2022 as the Vice President of Business Development. Thomas has been in the CRO industry for over 20 years, having held positions of increasing responsibility within Project Management and Business Development, with a focus on Phase 1 services. Based on his experience and thorough understanding of the drug development process, Thomas looks forward to collaborating with you to achieve your Phase 1 drug development needs.
- SPOTLIGHT ON: Anson Wu – Deputy Study Director
- Research Roundtable for Epilepsy: A Reflection by Dr. John Oldenhof
- FIX-DOSED COMBINATION: APPROACHING AN OLD QUESTION WITH A NEW CONCEPT
- FIX-DOSED COMBINATION: Global Development Strategy for Value Added Medicine
- BioPharma Services Bioanalytical Laboratory passes FDA inspection with flying colours